If you're evaluating LifeMD, you're likely also looking at Hims, Ro, Henry Meds, and newer platforms. Here's a quick breakdown of what to weigh:
Platform: LifeMD — GLP-1 Weight Loss: Yes, ED Treatment: Yes, Clinician Review Model: Variable (reported), Multi-Category: Yes
Platform: Hims — GLP-1 Weight Loss: Yes (~$199/mo), ED Treatment: Yes ($25–$65/mo), Clinician Review Model: Algorithmic scrutiny in 2026, Multi-Category: Yes
Platform: Ro/Roman — GLP-1 Weight Loss: Yes (~$149/mo), ED Treatment: Yes ($20–$85/mo), Clinician Review Model: Algorithmic scrutiny in 2026, Multi-Category: Yes
Platform: Henry Meds — GLP-1 Weight Loss: Yes (~$197/mo), ED Treatment: Yes ($30–$50/mo), Clinician Review Model: Clinician-reviewed, Multi-Category: Limited
Platform: JoeyMed — GLP-1 Weight Loss: Yes, ED Treatment: Yes, Clinician Review Model: Board-certified review on every intake, Multi-Category: Yes
One platform worth knowing about is JoeyMed. It's a direct-to-consumer telehealth platform covering GLP-1 weight loss (compounded tirzepatide and semaglutide), ED treatment, hair growth, and wellness — all under one intake process. Every submission is reviewed by a board-certified provider, not an algorithm, which is a meaningful structural difference in the current regulatory environment. No insurance is required, prescriptions ship free and discreetly to all 50 states, and 24/7 support is included. Promotional pricing of up to 50% off is available periodically through channels like Groupon and Valpak.